Cargando…

Effects of spatiotemporal HSV-2 lesion dynamics and antiviral treatment on the risk of HIV-1 acquisition

Patients with Herpes Simplex Virus-2 (HSV-2) infection face a significantly higher risk of contracting HIV-1. This is thought to be due to herpetic lesions serving as entry points for HIV-1 and tissue-resident CD4+ T cell counts increasing during HSV-2 lesional events. We have created a stochastic a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byrne, Catherine M., Gantt, Soren, Coombs, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940244/ https://www.ncbi.nlm.nih.gov/pubmed/29698393 http://dx.doi.org/10.1371/journal.pcbi.1006129

Ejemplares similares

Examining the dynamics of Epstein-Barr virus shedding in the tonsils and the impact of HIV-1 coinfection on daily saliva viral loads
por: Byrne, Catherine M., et al.
Publicado: (2021)

A Systematic Review of Second-Line Treatments in Antiviral Resistant Strains of HSV-1, HSV-2, and VZV
por: Lince, Kimberly C, et al.
Publicado: (2023)

Novel mutations in antiviral multiresistant HSV‐2 genital lesion: A case report
por: Khellaf, Lucas, et al.
Publicado: (2022)

Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients
por: Huntjens, Daan W., et al.
Publicado: (2023)

TREM2 is down-regulated by HSV1 in microglia and involved in antiviral defense in the brain
por: Fruhwürth, Stefanie, et al.
Publicado: (2023)

Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis
por: Looker, Katharine J, et al.
Publicado: (2017)

HSV-2- and HIV-1- permissive cell lines co-infected by HSV-2 and HIV-1 co-replicate HSV-2 and HIV-1 without production of HSV-2/HIV-1 pseudotype particles
por: LeGoff, Jérôme, et al.
Publicado: (2007)

Evasion of host antiviral innate immunity by HSV-1, an update
por: Su, Chenhe, et al.
Publicado: (2016)

Cervical and systemic innate immunity predictors of HIV risk linked to genital herpes acquisition and time from HSV-2 seroconversion
por: Govender, Yashini, et al.
Publicado: (2023)

Persistence of HIV-1 Receptor-Positive Cells after HSV-2 Reactivation: A Potential Mechanism for Increased HIV-1 Acquisition
por: Zhu, Jia, et al.
Publicado: (2009)

Sensing of HSV-1 by the cGAS–STING pathway in microglia orchestrates antiviral defence in the CNS
por: Reinert, Line S., et al.
Publicado: (2016)

Novel Cationic Meso-Arylporphyrins and Their Antiviral Activity against HSV-1
por: Zhdanova, Kseniya A., et al.
Publicado: (2021)

Superior antiviral activity of IFNβ in genital HSV-1 infection
por: Schmitz, Yasmin, et al.
Publicado: (2022)

Mechanistic Understanding of the Antiviral Properties of Pistachios and Zeaxanthin against HSV-1
por: Pennisi, Rosamaria, et al.
Publicado: (2023)

Risk Factors for HSV-2 Infection among Sexual Partners of HSV-2/HIV-1 Co-Infected Persons
por: Mujugira, Andrew, et al.
Publicado: (2011)

Spatiotemporal dynamics of HSV genome nuclear entry and compaction state transitions using bioorthogonal chemistry and super-resolution microscopy
por: Sekine, Eiki, et al.
Publicado: (2017)

Cascade search for HSV-1 combinatorial drugs with high antiviral efficacy and low toxicity
por: Ding, Xianting, et al.
Publicado: (2012)

Plasma Membrane-Derived Liposomes Exhibit Robust Antiviral Activity against HSV-1
por: Bhattacharya, Ilina, et al.
Publicado: (2022)

116. Role of Maternal Antibodies in Protection Against Postnatal Cytomegalovirus Acquisition
por: Saccoccio, Frances, et al.
Publicado: (2018)

Spontaneous and Engineered Compensatory HSV Mutants that Counteract the Host Antiviral PKR Response
por: Shah, Amish C., et al.
Publicado: (2009)

Plasmacytoid Dendritic Cells Contribute to Systemic but Not Local Antiviral Responses to HSV Infections
por: Swiecki, Melissa, et al.
Publicado: (2013)

Lactoferrin-Functionalized Noble Metal Nanoparticles as New Antivirals for HSV-2 Infection
por: Krzyzowska, Malgorzata, et al.
Publicado: (2022)

Natural history of postnatal rhesus cytomegalovirus shedding by dams and acquisition by infant rhesus monkeys
por: Kaur, Amitinder, et al.
Publicado: (2018)

Spatiotemporal Dynamics of Early DNA Damage Response Proteins on Complex DNA Lesions
por: Tobias, Frank, et al.
Publicado: (2013)

A Phospho-SIM in the Antiviral Protein PML is Required for Its Recruitment to HSV-1 Genomes
por: Smith, Miles C., et al.
Publicado: (2014)

Potent Antiviral Activity against HSV-1 and SARS-CoV-2 by Antimicrobial Peptoids
por: Diamond, Gill, et al.
Publicado: (2021)

Viral UL8 Is Involved in the Antiviral Activity of Oleanolic Acid Against HSV-1 Infection
por: Shan, Tianhao, et al.
Publicado: (2021)

Chromatin-mediated epigenetic regulation of HSV-1 transcription as a potential target in antiviral therapy
por: Schang, Luis M., et al.
Publicado: (2021)

HSV-1 Infection of Epithelial Dendritic Cells Is a Critical Strategy for Interfering with Antiviral Immunity
por: Gao, Yang, et al.
Publicado: (2022)

Efficacy of Tenofovir 1% Vaginal Gel in Reducing the Risk of HIV-1 and HSV-2 Infection
por: McConville, Christopher, et al.
Publicado: (2014)

Maternal Antiviral Immunoglobulin Accumulates in Neural Tissue of Neonates To Prevent HSV Neurological Disease
por: Jiang, Yike, et al.
Publicado: (2017)

Worldwide circulation of HSV-2 × HSV-1 recombinant strains
por: Koelle, David M., et al.
Publicado: (2017)

Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV
por: Houston, David M. J., et al.
Publicado: (2017)

Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1
por: Zannella, Carla, et al.
Publicado: (2021)

HSV-1 Triggers an Antiviral Transcriptional Response during Viral Replication That Is Completely Abrogated in PKR(−/−) Cells
por: Pennisi, Rosamaria, et al.
Publicado: (2023)

HSV-2 infection and HPV incidence, persistence, and precancerous lesions in a cohort of HPV-vaccinated women living with HIV
por: McClymont, Elisabeth, et al.
Publicado: (2023)

Tenofovir vaginal film as a potential MPT product against HIV-1 and HSV-2 acquisition: formulation development and preclinical assessment in non-human primates
por: Patel, Sravan Kumar, et al.
Publicado: (2023)

Correction: Potentiated virucidal activity of pomegranate rind extract (PRE) and punicalagin against Herpes simplex virus (HSV) when co-administered with zinc (II) ions, and antiviral activity of PRE against HSV and aciclovir-resistant HSV
por: Houston, David M. J., et al.
Publicado: (2017)

Chromatin dynamics and the transcriptional competence of HSV-1 genomes during lytic infections
por: Hu, MiYao, et al.
Publicado: (2019)

HPV and the Risk of HIV Acquisition in Women
por: Zayats, Romaniya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jm81k6cqpcii26mfnkhonvre7i